18 completed, 9 terminated, 8 unknown, 5 recruiting. 45 Phase 3, 14 Phase 2.
Follow Oxygen: new trials by email Literature Review of Oxygen trials Research Report on Oxygen
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Medical Nitrous Oxide Combined With Personalized Traumatic Script Exposure for the Treatment of Post-Traumatic Stress Disorder MEOPA (Nitrous Oxide/Oxygen Premix), Medical Air in Oxygen, Personalized Traumatic Script Exposure - PTSD - Post Traumatic Stress Disorder | Phase 3 | Not yet recruiting | University Hospital, Tours | 96 | 2027-01-01 | 2026-11-10 |
| Normobaric Hyperoxia With Extended-Window Endovascular Therapy for Acute Ischemic Stroke (OPENS-EXTEND) Oxygen (Normobaric Hyperoxia), Sham Normobaric Hyperoxia, Endovascular Therapy - Stroke, Acute, Neuroprotection | Phase 3 | Not yet recruiting | Weifang Medical University | 314 | 2026-09-01 | 2026-07-21 |
| Intracervical Balloon Placement With Nitrous Oxide Administration Nitrous oxide, Oxygen - Labor Pain, Induced; Birth | Phase 3 | Withdrawn | Jefferson Drapkin | 2026-03-01 | 2026-09-17 | |
| Ozone Treatment in Paresthesia (Numbness, Tingling) Secondary to Chemotherapy-induced Peripheral Neuropathy Ozone therapy, Oxygen (placebo) - Chemotherapy Induced Peripheral Neuropathy (CIPN), Paresthesia | Phase 2 / Phase 3 | Recruiting | Bernardino Clavo, MD, PhD | 42 | 2025-02-07 | 2026-09-18 |
| Gut Microbiome Profiles in Patients With Chemotherapy-induced Neuropathy in the RCT OzoParQT (NCT06706544). Ozone therapy, Oxygen (placebo) - Chemotherapy Induced Peripheral Neuropathy (CIPN), Paresthesia | Phase 2 / Phase 3 | Recruiting | Bernardino Clavo, MD, PhD | 42 | 2025-02-07 | 2026-09-25 |
| Oxygen Targets in Acute Heart Failure With Pulmonary Congestion Oxygen - Acute Heart Failure, Pulmonary Congestion | Phase 2 / Phase 3 | Completed | Copenhagen University Hospital, Hvidovre | 135 | 2024-02-01 | 2026-10-26 |
| NO During CPB in Neonates to Reduce Risk of AKI Nitric Oxide, Oxygen - AKI, CHD - Congenital Heart Disease | Phase 3 | Recruiting | Children's Hospital Medical Center, Cincinnati | 40 | 2023-01-10 | 2026-08-05 |
| The Effect of Oxygen Given to Patients in the Postoperative Period on Nausea and Vomiting oxygen - Oxygen, Postoperative Nausea and Vomiting | Phase 3 | Unknown | Selcuk University | 111 | 2022-05-03 | 2020-10-22 |
| Efficacy of Nasal Oxygen Therapy to Reduce Postoperative Complications in Ankle Trauma Surgery in At-risk Patients: a Randomized Pilot Study. Oxygen, no oxygen therapy - Ankle Fractures | Phase 3 | Active not recruiting | Nantes University Hospital | 200 | 2022-04-09 | 2026-01-14 |
| Intermittent Versus Continuous Surface O2 During HMP of DCD Kidneys Oxygen - Delayed Graft Function, Kidney Transplant; Complications | Phase 3 | Unknown | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 60 | 2022-03-20 | 2024-05-23 |
| Nitrous Oxide for Pain Management During IUD Insertion in Nulliparous Adolescent Women Nitrous oxide gas for inhalation, Oxygen Gas for Inhalation - Contraceptive Devices, Long-Acting Reversible Contraception | Phase 2 / Phase 3 | Withdrawn | Boston Children's Hospital | 2021-06-01 | 2022-09-16 | |
| Hyperbaric Versus Normobaric Oxygen Therapy for COVID-19 Patients Oxygen - Covid19 | Phase 2 / Phase 3 | Unknown | Ottawa Hospital Research Institute | 234 | 2021-04-15 | 2021-11-01 |
| Ozone Therapy in Chemotherapy-induced Peripheral Neuropathy: RCT (O3NPIQ) Ozone, Oxygen - Chemotherapy-induced Peripheral Neuropathy, Pain, Neuropathic | Phase 2 / Phase 3 | Recruiting | Bernardino Clavo, MD, PhD | 42 | 2020-11-30 | 2026-09-25 |
| Non-Invasive Vagal Nerve Stimulation in Opioid Use Disorders Non invasive VN stimulation (nVNS), Oxygen (15-O) Water, Sham Stimulation - Substance-Related Disorders, Substance Use Disorders | Phase 3 | Completed | Emory University | 20 | 2020-11-13 | 2023-09-13 |
| Perioperative Respiratory Care and Outcomes for Patients Undergoing High Risk Abdominal Surgery Chlorhexidine mouthwash, Oxygen - Infection, Pneumonia | Phase 3 | Recruiting | University of Birmingham | 12942 | 2020-11-13 | 2025-02-19 |
| Effect of Intrapartum Oxygen Administration on Fetal and Early Neonatal Outcomes 100% Oxygen, 21% oxygen - Fetal Distress, Birth Asphyxia | Phase 3 | Unknown | Makerere University | 1108 | 2020-03-16 | 2020-03-26 |
| Ozone Therapy in Refractory Ischemic Heart Disease. Ozone, Oxygen - Ischemic Heart Disease | Phase 2 / Phase 3 | Terminated | Bernardino Clavo, MD, PhD | 1 | 2020-02-26 | 2022-04-04 |
| Protective Effect of Aspirin on COVID-19 Patients Aspirin 100mg - Novel Coronavirus Pneumonia, Aspirin | Phase 2 / Phase 3 | Unknown | Xijing Hospital | 128 | 2020-02-10 | 2020-04-28 |
| The Effect of Hyperbaric OxygeN Therapy on brEast Cancer Patients With Late Radiation toxicitY - UMBRELLA HONEY Trial Hyperbaric oxygen therapy - Breast Cancer, Radiation Toxicity | Phase 3 | Completed | UMC Utrecht | 189 | 2019-08-28 | 2025-04-03 |
| Nitrous Oxide for the Treatment of Complex Regional Pain Syndrome Nitrous Oxide, Oxygen - Complex Regional Pain Syndrome | Phase 3 | Completed | The Cleveland Clinic | 44 | 2019-07-02 | 2024-02-09 |
Showing 20 of 45. Sign in to see all of them.
Pain (4) · Anxiety Disorders (3) · Heart Failure (3) · Acute Coronary Syndrome (2) · Angina, Unstable (2) · Depression (2) · Heart Defects, Congenital (2) · Hypesthesia (2) · Inflammation (2) · Myocardial Infarction (2) · Non-ST Elevated Myocardial Infarction (2) · Paresthesia (2) · Postoperative Complications (2) · Premature Birth (2) · Pulmonary Disease, Chronic Obstructive (2)
Bernardino Clavo, MD, PhD (4) · Assistance Publique - Hôpitaux de Paris (2) · Karolinska Institutet (2) · Air Liquide SA (1) · Air Liquide Santé International (1) · Bayside Health (1) · Beersheva Mental Health Center (1) · Boston Children's Hospital (1) · Brigham and Women's Hospital (1) · Charite University, Berlin, Germany (1) · Children's Hospital Medical Center, Cincinnati (1) · Cliniques universitaires Saint-Luc- Université Catholique de Louvain (1) · Copenhagen University Hospital, Hvidovre (1) · Emory University (1) · Göteborg University (1)
United States (12) · France (9) · Spain (5) · Sweden (4) · Belgium (3) · Germany (3) · United Kingdom (3) · Brazil (2) · Canada (2) · Netherlands (2) · Australia (1) · China (1) · Denmark (1) · India (1) · Israel (1)
Bernardino Clavo, MD, PhD (4) · Pedro G Serrano-Aguilar, MD, PhD (2) · Anil Gupta, MD, PhD (1) · Cai Yue (1) · Celestina Amador, MD, PhD (1) · Faruk Cicekci (1) · Frederic T. Billings, IV, MD, MSc (1) · Gustavo M Callico, Prof, PhD (1)
PMID 19260079, PMID 20405117, PMID 21427067, PMID 21575276, PMID 21835837, PMID 22147778, PMID 23102757, PMID 23549581, PMID 24576515, PMID 24687190, PMID 24733808, PMID 25699252, PMID 26521922, PMID 26653189, PMID 27736154, PMID 27783918, PMID 28651648, PMID 28844200, PMID 29087741, PMID 29226465, PMID 30767504, PMID 30803886, PMID 31081342, PMID 31473600, PMID 31779159, PMID 31838113, PMID 32379556, PMID 33246494, PMID 33576075, PMID 33738491, PMID 33791349, PMID 35096723, PMID 36041704, PMID 37489818, PMID 38329746, PMID 39110454, PMID 40255646, PMID 40548916, PMID 40673571, PMID 40929650, PMID 41323959, PMID 41433250, PMID 41572235
2004 (1), 2018 (1), 2019 (1), N01HR761971 (1), R01GM112871 (1), U24HL140412 (1), UG3DA048502 (1)